Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

Elmer CL

Diseases
Phomosis
Country
Germany
Registration Year
2014
Manufacturer
Bayer
Offers: 1
Where to buy
Price range
6 262 - 6 262 UAH
Views
5
Reviews
0
Producer
Bayer
Description Elmer CL
The winter rapeseed hybrid Elmer CL is a high-yielding and stress-tolerant plant developed by BASF (Bayer) for the Clearfield® system. This hybrid features medium-early maturity and combines high winter hardiness, lodging resistance, and tolerance to the disease phoma. Elmer CL exhibits active autumn growth, which contributes to successful adaptation and yield formation under various climatic conditions.

Elmer CL has a high yield potential, reaching 40-55 c/ha, making it an attractive choice for agricultural producers. The hybrid has a medium plant height of about 165-170 cm and an average pod length of 6-7 cm. It is distinguished by very high oil content and low glucosinolate levels, positively affecting product quality. The hybrid's flowering onset is medium, and its autumn development and winter hardiness are rated as high.

The Elmer CL hybrid is suitable for various cultivation technologies, including minimal soil tillage, and demonstrates high suitability for early and late sowing. The recommended seeding rate is 450-500 thousand seeds per hectare. Due to its weed resistance, including to crucifers, and high lodging and phoma resistance, Elmer CL is an effective solution for enhancing the productivity and quality of winter rapeseed yields.
Specifications Elmer CL
Diseases
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Growing Season
120-130 days
Yield Potential
40-50 ц/га
Herbicide Resistance
Clearfield
Plant: height
160-170 cm
Number of plants per hectare
400 thousand pcs/ha
500 thousand pcs/ha
Glucosinolate Content, mmol
9-10
Erucic Acid Content
Low
Plant: Branching
Average
Country
Germany
Registration Year
2014
Catalog
Varieties
Technical Crops
Manufacturer
Bayer
Where to buy Elmer CL
Loading...
Reviews Elmer CL
0comments
Sort by:Popular first
No comments yet.